In addition, it was shown that IL-1 can promote MM metastasis through NF-κB pathway activation of endothelial cells, while the use of the IL-1 receptor antagonist reduced lung metastasis in mice with B16 melanoma. This evidence concerns the gene NFKB1 and melanoma.